Armata Pharmaceuticals, Inc. filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-07-20. Between them they name 2 people. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: David House, Chief Financial Officer, effective 2026-07-17
On July 17, 2026, the Board of Directors (the " Board ") of Armata Pharmaceuticals, Inc. (the " Company ") promoted and appointed David House as the Company's Chief Financial Officer, effective July 17, 2026.
Reported
Such cash retainer will be pro-rated based on the effective date of Dr. Gilmer's appointment to the Nominating and Corporate Governance Committee.
Appointed: Daniel Gilmer, Director, effective 2026-04-24
On April 27, 2026, Armata Pharmaceuticals, Inc. (the "Company") announced that the Board of Directors (the "Board") appointed Dr. Daniel Gilmer, 39, as a member of the Board, effective as of April 24, 2026, to serve until the Company's next annual meeting of the Company's shareholders.
Find people with the same kind of experience as the Chief Financial Officer at Armata Pharmaceuticals, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Armata Pharmaceuticals, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Armata Pharmaceuticals, Inc. is in the news or changes leadership.
Get an alert when Armata Pharmaceuticals, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Armata Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.